Whitehawk Therapeutics, Inc.
WHWK
$1.71
$0.05993.63%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Net Income | -52.62M | 73.02M | -18.27M | -12.55M | -14.58M |
Total Depreciation and Amortization | 16.00K | 57.00K | 47.00K | 47.00K | 49.00K |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | 3.09M | -85.67M | 1.75M | 2.34M | 2.57M |
Change in Net Operating Assets | -3.45M | 733.00K | 1.43M | -5.53M | 2.81M |
Cash from Operations | -52.96M | -11.86M | -15.05M | -15.69M | -9.16M |
Capital Expenditure | -1.00K | -551.00K | -186.00K | -188.00K | -541.00K |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | 0.00 | 101.36M | -- | -- | -- |
Other Investing Activities | -28.83M | 14.69M | 13.32M | 5.27M | -3.03M |
Cash from Investing | -28.83M | 115.50M | 13.13M | 5.09M | -3.57M |
Total Debt Issued | -- | -- | -- | -- | -- |
Total Debt Repaid | -- | -- | -- | -- | -- |
Issuance of Common Stock | 29.00K | 100.02M | 52.00K | 0.00 | 94.00K |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -879.00K | -4.82M | 1.00K | 0.00 | -7.00K |
Cash from Financing | -850.00K | 95.20M | 53.00K | 0.00 | 87.00K |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | -82.63M | 198.84M | -1.87M | -10.60M | -12.64M |